Project Number 5R44AG062129-03 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Mechanism of action of oligomer-displacing Alzheimer investigation drug; CT1812:Receptor interactions and signaling pathways Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 1. Amyloid beta e. Amyloid beta Clearance Researcher and Organization Principal Investigator IZZO, NICHOLAS JOHN Principal Investigator First Name NICHOLAS JOHN Principal Investigator Last Name IZZO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-187: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $729,226 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
